KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Change in Acquisitions & Divestments (2020 - 2025)

Historic Change in Acquisitions & Divestments for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $192.6 million.

  • Oscar Health's Change in Acquisitions & Divestments rose 13544.14% to $192.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $670.7 million, marking a year-over-year decrease of 994.5%. This contributed to the annual value of $670.7 million for FY2025, which is 994.5% down from last year.
  • Per Oscar Health's latest filing, its Change in Acquisitions & Divestments stood at $192.6 million for Q4 2025, which was up 13544.14% from $210.8 million recorded in Q3 2025.
  • Over the past 5 years, Oscar Health's Change in Acquisitions & Divestments peaked at $390.6 million during Q4 2023, and registered a low of $66.2 million during Q3 2024.
  • In the last 5 years, Oscar Health's Change in Acquisitions & Divestments had a median value of $181.0 million in 2022 and averaged $204.2 million.
  • In the last 5 years, Oscar Health's Change in Acquisitions & Divestments surged by 37526.91% in 2021 and then tumbled by 7905.97% in 2024.
  • Over the past 5 years, Oscar Health's Change in Acquisitions & Divestments (Quarter) stood at $202.0 million in 2021, then dropped by 25.64% to $150.2 million in 2022, then skyrocketed by 159.95% to $390.6 million in 2023, then tumbled by 79.06% to $81.8 million in 2024, then surged by 135.44% to $192.6 million in 2025.
  • Its last three reported values are $192.6 million in Q4 2025, $210.8 million for Q3 2025, and $111.5 million during Q2 2025.